The U.S. health department is canceling or scaling back 22 BARDA-backed mRNA projects worth nearly $500 million, shifting ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer's weekly Canadian shipment of 2.4 million doses was temporarily delayed this week, causing provinces to change appointments to Moderna due to an increase in supply of that shot and to avoid ...

In clinical trials, Moderna showed 94.1 per cent efficacy in preventing COVID-19 two weeks after a second dose, comparable to Pfizer’s 95 per cent.

Pfizer is the only vaccine currently approved for people aged 12 to 17. "Any youths who are affected by the delay will be contacted directly to discuss arrangements for immunization," the SHA said.